AI Picks Parkinson’s
Could artificial intelligence help repurpose old drugs for sufferers of the degenerative disorder?
James Strachan |
A collaboration between Parkinson’s UK and The Cure Parkinson’s Trust (CPT) has been awarded the inaugural BenevolentAI Award (1) - a competition run by BenevolentAI and the UK’s Association of Medical Research Charities (AMRC). The aim? To help charities accelerate medical research to potentially develop new therapies using artificial intelligence (AI).
The winning entry focused on repurposing existing drugs for use against Parkinson’s. “[the winning entry] offers the potential to provide a quick route to patient benefit, and their virtual biotechnological model meant they also had the support network to quickly take things forward”, says James Chandler, VP corporate affairs at BenevolentAI.
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!